Showing results (111-120 of 146) with videos related to
Sort By:
Pageof 15
Toxicology Letters|October 12, 2010
Distribution of melamine in rat foetuses and neonatesC Y Chu, K O Chu, Judy Y W Chan, et al.Lung Cancer (Amsterdam, Netherlands)|May 1, 2021
Durability of CNS disease control in NSCLC patients with brain metastases treated with immune checkpoint inhibitors plus cranial radiotherapySally C M Lau, Christopher Poletes, Lisa W Le, et al.Journal of Psychiatric and Mental Health Nursing|October 12, 2011
Insight in Chinese schizophrenia patients: a 12-month follow-upY Wang, Y-T Xiang, C-Y Wang, et al.Pharmacopsychiatry|January 5, 2002
Cytochrome P450 2D6 genotyping and association with tardive dyskinesia in Chinese schizophrenic patientsL C Lam, M M Garcia-Barcelo, G S Ungvari, et al.Menopause (New York, N.Y.)|June 25, 2013
A randomized, double-blind, controlled trial of a Chinese herbal formula (Er-Xian decoction) for menopausal symptoms in Hong Kong perimenopausal womenLinda L D Zhong, Yao Tong, Grace W K Tang, et al.Systematic and Applied Microbiology|December 12, 2003
Actinomyces hongkongensis sp. nov. a novel Actinomyces species isolated from a patient with pelvic actinomycosisPatrick C Y Woo, Ami M Y Fung, Susanna K P Lau, et al.Antibiotics (Basel, Switzerland)|September 28, 2024
Antibiotic Susceptibility of Aerobic and Facultative Anaerobic Gram-Negative Rods in Hong Kong and Implications on Usefulness of Ceftazidime-Avibactam and Ceftolozane-TazobactamJade L L Teng, Elaine Chan, Tsz Tuen Li, et al.Journal of Orthopaedic Translation|January 13, 2021
Satisfactory long-term survival, functional and radiological outcomes of open-wedge high tibial osteotomy for managing knee osteoarthritis: Minimum 10-year follow-up studyLawrence C M Lau, Jason C H Fan, Kwong-Yin Chung, et al.Therapeutic Advances in Medical Oncology|October 30, 2025
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastasesMaisam Makarem, Tuan Hoang, Mitchell J Elliott, et al.Clinical Lung Cancer|February 14, 2021
Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint InhibitorsSally C M Lau, Aline Fusco Fares, Lisa W Le, et al.Pageof 15